argyrotsipi/train-dataset huggingface dataset:
Trade Bill — House of Lords, 2020-12-07
Topic: Health
Shaista Sheehan (Liberal Democrats, Centre to centre-left): My Lords, Amendment 43 in my name provides for safeguards to trade agreements to ensure affordable access to medicines for all. I thank my noble friend Lord Purvis of Tweed and the noble Lord, Lord Alton, for adding their names. I express my support for Amendment 11 in the names of the noble Baroness, Lady Thornton, the noble Lords, Lord Freyberg and Lord Patel, and my noble friend Lord Fox. It dovetails nicely with my Amendment 43 in seeking to protect the NHS and connected services from control through free trade agreements; Amendment 43 seeks to affirm fair access to affordable medicines for international agreements to which the UK is already a party The monopoly system created by the pharmaceutical business model is entrenched globally through the WTO’s 1995 TRIPS agreement—the Agreement on Trade-Related Aspects of International Property Rights. Included within it are provisions to safeguard public health. However, concerns about affordable medicines in developing countries, particularly access to antiretroviral drugs in the face of the HIV/AIDS epidemic, led to the Doha declaration in 2001. These identified options open for Governments to address public health needs, which are known as flexibilities. The importance of such flexibilities was highlighted by their inclusion in the UN’s sustainable development goals However, despite these safeguards, the misuse and abuse of these monopoly rights continue and are taking precedence over human rights in all countries of the world, not just developing ones. The NHS’s spiralling drugs bill led even the Health Secretary, Matt Hancock, to protest that pharmaceutical companies are "ripping off taxpayers". I have no objection to profit-making by companies, but I object vehemently to people suffering and dying needlessly under the NHS because of quite obscene profit-taking by pharmaceutical companies, as happened with Vertex’s cystic fibrosis drug Orkambi. In South Africa, private health companies are charging $39,000—an obscene amount—for Trastuzumab, a WHO essential drug to treat breast cancer. This is a human rights issue.
Covid-19: Contracts and Public Inquiry — House of Commons, 2021-07-07
Topic: Health
David Michael Doogan (Scottish National Party, Centre-left): Let me share with the hon. Lady my appreciation that the vaccine roll-out has been a tremendous success. I am not certain that any of my colleagues said that it was not a tremendous success. Does she agree, however, that it is the one thing that this Government got right in the whole pandemic, and that a vaccine never brought anybody back from the dead?
Health and Care Bill — House of Lords, 2022-02-04
Topic: Health
Andrew Lansley (Conservative, Centre-right): The noble Baroness is drawing me into what is a very important debate, but I do not think it is this one in this group. We will come on to it perhaps on Amendment 259 at a later stage. I do not disagree that we have not succeeded where alcohol consumption is concerned, but the nature of the problem has manifested itself more recently, especially in smaller numbers of people consuming alcohol, some not at all, but those who do very often doing so through binge drinking, which is exactly what is giving rise to what we are all most concerned about, which is the significant harm that is resulting for those people. We need to think behaviourally about the nature of the problem in order to find behaviourally what is the nature of the solution I need to stop, but I shall raise just one point with my noble friend on the Front Bench. I started with nutrient profiling. Nutrient profiling is terribly important. The noble Lord, Lord Clement-Jones, made the point that we do not get to look at that, but what it says is terribly important. As I understand it, we are due for a revision, but we have not yet seen it. There was a 2013 study that looked at our nutrient profiling and compared it to that of the WHO and five European countries. It concluded that, in relation to a large number of processed and packaged foods, under our system 47% would be able to be advertised to children, while under the WHO system it was 32%. There is a significant difference in what one puts into the nutrient profiling. It is not an objective truth, and putting alcohol in it completely misses the point, since it is not constructed around that proposition. I ask my noble friend to tell us a bit more about the nutrient profiling process, the timetable, the evidence and how we are going to put it together to meet the objectives under the Bill.
Health and Care Bill — House of Lords, 2022-02-04
Topic: Health
Bernard Francisco Ribeiro (Conservative, Centre-right): My Lords, would it be possible to collect data to substantiate what my noble friend has said about the reduction in people going overseas to get organs for transplantation? Can we get some figures to be absolutely clear that the numbers are reducing and not continuing, as some of us fear?
Health and Care Bill — House of Lords, 2022-02-04
Topic: Health
Joanna Penn (Conservative, Centre-right): My Lords, I am grateful to all the noble Baronesses who have spoken in this group, and in particular to my noble friend Lady Cumberlege for all the work that she has done on patient safety. I have noted their points very carefully and look forward to the further discussion of transparency and scrutiny of healthcare professionals in the debate on the next group where, on the point that the noble Baroness, Lady Thornton, made about payments from pharma and so on, it is my understanding that it will be on industry to declare those nationally.
Health and Care Bill — House of Lords, 2022-02-04
Topic: Health
Julia Frances Cumberlege (Conservative, Centre-right): My Lords, I thank so much the noble Lords who have supported this amendment. I always welcome the support of the noble Baroness, Lady Brinton, because she is clear, concise and very authoritative; she commented that doctors already have a duty and that we should see progress. As always, the noble Baroness, Lady Finlay, was accurate; she talked about accuracy and accessibility for patients, and said that the register really is so important because it actually safeguards doctors, a point that has been put to us by some doctors. The noble Baroness, Lady Neuberger, is a chair of one of our great hospitals in London, and I was so grateful for her contribution. She went to her medical directors and found out that they thought this was an ethical way forward and should be encouraged. I also thank her for her generous remarks about the report—I would just like to say it is not my report; it was the team’s report, and I had some really good people on the team. I thank the noble Baroness, Lady Thornton, who was right: it has to be a national register, not a local one, and it has to be accessible to patients In summing up, I thank the Minister very much for her comments. There is such feeling about this in the country that it would be very helpful if she could convene a meeting with me, my team and the GMC to discuss this together. I think that a little more persuasion—especially from sources such as those on the Front Bench—would make all the difference.
Covid-19 Update — House of Commons, 2021-06-28
Topic: Health
Marion Fellows (Scottish National Party, Centre-left): Now that the Health and Social Care Secretary is in post, will he break with his predecessor’s outright refusal to deliver the pay rise to NHS staff in England that they deserve? Will he, at a minimum, commit to matching NHS pay rates in Scotland, delivering a pay rise for staff in England, and to providing more money in consequentials to help devolved Governments support NHS staff in devolved nations?
European Union (Withdrawal) Bill — House of Lords, 2018-03-12
Topic: Health
Norman Warner (Crossbench, Unknown): I think the noble Baroness might want to have a conversation with the noble Lord sitting on her left. As a former pharmaceuticals and life sciences Minister, I know only too well that the pharmaceutical industry, including the biotech industry, makes decisions on planning its clinical trials quite a long way ahead. It would be a pretty strange company that, knowing there were going to be a new set of rules for 27 countries in the EU, which it would be of much greater benefit to participate in, entered into clinical trials with the one country that was not in that set of arrangements and which was using the 2004 clinical trials directive. Can the Minister explain how she expects big pharma and biotech companies to make sensible investment decisions on the basis of the sorts of assurances she has given the House in this debate?
European Union (Withdrawal) Bill — House of Lords, 2018-03-12
Topic: Health
Ajay Kakkar (Crossbench, Unknown): I wonder whether the noble Baroness will take this slightly different point. If, as is argued, the clinical trials regulation will not form part of the applied European law at the time of exit, clinical trials will still have to be conducted under some form of law in our country, and that will be the 2004 directive that currently applies. If that goes forward, what ultimately will happen is that everything we know that is wrong with that directive, and which has been corrected by the new regulations, will apply in our own country. Even if we continue to be active participants in clinical research, we will be so under the less satisfactory situation of the current 2004 directive unless the Government decide to modify that directive. As there must be a legal basis for undertaking clinical research, does it not seem logical simply to apply what we have already agreed is a sensible approach rather than having to reinvent a new basis for legal provision to undertake clinical trials in our country?
European Union (Withdrawal) Bill — House of Lords, 2018-03-12
Topic: Health
Ajay Kakkar (Crossbench, Unknown): Does not the Minister consider there to be a substantial risk? As I understand it, non-member states of the European Union are obliged to be fully compliant with the 2004 clinical trials directive. If we become non-members of the European Union and do not have an agreement in this area prior to leaving, will we not be forced to continue under the 2004 directive if we wish to participate in the data and information generated from clinical research being applicable more broadly for those who wish to take their arguments for adoption of those findings, and authorisation of new medicinal products as a result of those findings, in the European Union?
Topical Questions — House of Commons, 2021-06-08
Topic: Health
Kirsten Frances Oswald (Scottish National Party, Centre-left): The British Medical Association has warned that the freezing of the lifetime and annual pensions tax allowance until April 2026 could significantly impact the retention and overtime of health and care staff, with 72% of doctors that it surveyed saying that it would make them more likely to retire early. What consideration has been given to the BMA’s proposal of offering a tax unregistered scheme, similar to that of the judiciary, for those in the NHS?
Ajax Programme — House of Commons, 2021-06-08
Topic: Defense
David Michael Doogan (Scottish National Party, Centre-left): There is in the UK no shortage of MOD procurement debacles to draw on, such as the £4 billion Nimrod MRA4 scrapped before service or the Mk 3 Chinooks—half a billion pounds of aircraft that could not fly low or in bad weather—but this multibillion-pound Ajax failure sets a new low. The UK Government have presided over a procurement project that would see soldiers arriving late for operations in vehicles only capable of a pedestrian 20 mph, with a human endurance range of no further than 30 miles, and then unable to fight duty due to sensory impairment and pain caused by these £3.5 billion boneshakers. Can the Minister confirm that the sight system manufactured by Thales in Scotland is working perfectly and is unconnected with this broader failure? Where was the intelligent client at the heart of this project, and where was the learning from previous procurement fiascos? Is the Minister accepting personal responsibility for this debacle, and if so, how does he plan to atone?
European Union (Withdrawal) Bill — House of Lords, 2018-03-12
Topic: Health
Narendra Babubhai Patel (Crossbench, Unknown): My Lords, it is difficult for me to sum up. The message is quite clear to me, although that might merely be perception, that my friend, the noble Baroness, Lady Goldie, is in some difficulty. It is quite clear to all those who understand the amendment—and, more importantly, the European trials regulation and the law as specified in the Bill—that there is no reason why we cannot incorporate this into the Bill. The noble Lord, Lord Warner, suggested that we might need to bring another amendment; I suppose he means with the view to having a vote. That was not my intention when I tabled the amendment. It was merely to clarify the Government’s position on importing the European trials regulation into the Bill as we are the prime movers of the regulation and we are formulating it. The solution identified by the noble and learned Lord, Lord Mackay of Clashfern, seems to be the answer to cover all such regulations that we might have agreed to and might come into force. This is not the first time that he has come to my rescue. He has done so twice before, on admixed embryos and on mental health having equal esteem. Both times they were put to the vote and the votes were won—so that is a warning I hope the Minister might agree that more work needs to be done on this by Ministers. I am glad to understand that the noble Lord, Lord Callanan, is to meet with Cancer Research UK and others at some stage in March, I assume to discuss this and other science issues. I hope he will agree that there might be a place for the Ministers to meet and see whether there is a solution. Otherwise, I fear that either there will be an amendment in the form suggested by the noble and learned Lord, Lord Mackay, or, if it is not me, somebody else will table an amendment. We can tell from the support this amendment received even from strong Brexiteers such as the noble Lords, Lord Lawson and Lord Forsyth, and the noble Viscount, Lord Ridley, that such an amendment might be carried.
Ajax Programme — House of Commons, 2021-06-08
Topic: Defense
David Melvyn Linden (Scottish National Party, Centre-left): Unfortunately, this is not the first time that the MOD has been found not to have undertaken the proper due diligence with respect to its hardware. There are serious questions about not only this hardware, given the reports of potential injuries to personnel, but the process through which it was selected, developed and commissioned. Given tenders such as the Nimrod MRA4 and others like it, the British Government have billions of pounds lying in the balance. Will they therefore commit to reviewing how they handle such tenders?
Covid-19 Update — House of Commons, 2021-07-22
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): I wish you, colleagues and all the House staff a safe and happy summer recess, Mr Speaker. Clearly, vaccination is critical to fighting this pandemic. We all need to encourage uptake among younger adults, but is the Minister in a position to guarantee sufficient supplies of Pfizer or Moderna vaccines to vaccinate them before the end of September? Whether this is done legally, as in the case of care homes staff, or through excluding people from social activities, does he recognise that making vaccination mandatory can increase distrust among those who are hesitant and drive them to become outright vaccine refusers? Despite the talk about caution, covid cases in England were already surging when the Government ploughed ahead with lifting all legal restrictions on Monday. Although vaccination has reduced the hospitalisation rate to between 2% and 3%, the Secretary of State suggested that covid cases could soar to 100,000 a day, which would result in 2,000 to 3,000 admissions, which is similar to what happened in the first wave. Does the Minister really not recognise that that would put health services under enormous pressure and cause the patient backlog to grow further? Are the Government even considering the impact of uncontrolled virus spread on vulnerable people, the incidence of long covid or the risk of generating yet another variant, with even greater vaccine resistance than delta? Finally, what contingencies are being put in place in case during recess the Government need to reintroduce covid restrictions, as has happened in Israel and the Netherlands?
Covid-19 Update — House of Commons, 2021-07-22
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): Mr Speaker, may I add my party’s thanks to you, to the House staff and to everyone across these islands who has worked so hard to save and preserve life during the pandemic I want to pick up on a vital component of vaccination that I believe the Government need to give great attention to. It will not have escaped the Minister’s attention, and anyone who has attended the regular briefings that we have had around the virus will have seen in Professor Van-Tam’s heat maps the distribution and upward spread of the virus, whereby it seeds in the younger population and exponentially grows up through the ages I really want to ask the Minister why he thinks the JCVI are being extremely cautious in extending vaccination to 12 to 17-year-olds, given that the US Centres for Disease Control and Prevention has now been vaccinating that population in the States—with some concerns, but, I think, manageable numbers of concerns—and why we are not progressing more vigorously to vaccinate that population and are limiting it to those with underlying health concerns or those related to people with underlying health concerns. There is a fundamental advantage to vaccinating this group, because it will increase their wellbeing and improve their access to schooling after their holidays, but, more importantly, it acts as—
Covid-19 Update — House of Commons, 2021-07-22
Topic: Health
James Neale Hanvey (Scottish National Party, Centre-left): I will finish now, Mr Speaker; I apologise Does the Minister not see the advantage of delivering those vaccines now, and what do we do if we decide that that needs to go live during the recess?
Arrangement of Business — House of Lords, 2021-10-11
Topic: Health
John McFall (Labour, Centre-left): My Lords, when the 10 minutes allocated for each Question is over, the clerk will stand and nod to indicate that the time for the Question has elapsed. I notice now that the clocks are going to be working; at one stage we were told that they were not Members will have read my message last week summarising actions that we can all continue to take to lessen the risk of Covid to ourselves and to the staff of the House. I would particularly like to emphasise that Members are encouraged to wear face coverings, in line with current government guidance and commission endorsement, which expects and recommends that individuals continue to wear face coverings in crowded and enclosed spaces.
Conscientious Objection (Medical Activities) Bill [HL] — House of Lords, 2018-03-23
Topic: Health
David Alton (Crossbench, Unknown): ‘I was very grateful that the gynaecologist who saw my own children into the world did not support abortion. That gave my wife and I great confidence in the lady who was our gynaecologist. I think there should be scope within the service for people to have alternative views. If the phrase "don’t join the service" that the noble Baroness used were to apply, it would mean that people like that would not be able to join the service in the first place Another change that has taken place in these years is that it was never envisaged in 1967 that abortion would happen on a regular day-by-day basis on the scale on which it is taking place. In fact, the noble Lord, Lord Steel, often said that it would occur only in rare and exceptional circumstances. There are now examples of some people who have had eight abortions under the National Health Service. You have to ask the question the noble Baroness often asks: "Why is not more done earlier to find alternatives to this?" That too should be in the scope of an inquiry into the workings of the 1967 Act, and so too should be the issue of gender abortions. If I was working in the National Health Service and was told that I had to facilitate the ending of the life of a little girl merely because she was a little girl, I would say no. The 1967 Act surely does not allow for that, and yet we know that there have been such cases and that the authorities decided not to take any legal action. Indeed, there was a vote in another place on a Bill to outlaw such gender abortions. It was lost by 201 votes to 292, so this is not the realms of fantasy. Noble Lords have to ask themselves precisely what their red line would be in regard to questions such as this I conclude by giving two opinions from people who have thought about these things in great detail. One is from Professor Andrew Tettenborn, who said: "The point matters a great deal. Many NHS hospitals now put abortion and other controversial procedures out to tender (a matter itself a cause for concern … and so organisation rather than participation is increasingly what will be demanded from … unwilling staff" I also refer the Committee to the review of Dr Mary Neal, senior lecturer in law at Strathclyde University, who said: "The core purpose of any conscience provision is to protect individuals from having to share in moral responsibility for something they consider to be seriously wrong. Since the current law leaves some of those who would share in responsibility unprotected, it fails to fulfil this core purpose" So when the noble Lord, Lord Steel, said in 1967: "The Bill imposes no obligation on anyone to participate in an operation", I believe he was sincere. When he also said that the "conscience" clause, "also gives nurses and hospital employees a clear right to opt out"—[Official Report, Commons, 13/7/1967; col. 1318.], I believe that is what he intended. I do not believe he intended that people such as Mary Doogan should lose their job. That is why my noble friend’s Bill is so important.
Intermediate-range Nuclear Forces Treaty — House of Lords, 2019-02-05
Topic: Defense
Menzies Campbell (Liberal Democrats, Centre to centre-left): Will the Minister join me in putting aside questions of blame and responsibility, and consider the nature of nuclear arms control? It can reasonably be said that its architecture is crumbling before our eyes. It is not just the INF treaty; it is the Iran nuclear treaty, the prospects for renewal of the Strategic Arms Reduction Treaty between the United States and Russia—which are generally now described as very unlikely—and the fact that the comprehensive test-ban treaty, first available in September 1996, is still not yet in force. We have in front of us, in 2020, the next review conference of the nuclear non-proliferation treaty. Would the Minister like to share with us precisely what position the United Kingdom is going to take in 2020 on the nuclear non-proliferation treaty, given that all around us it appears that nuclear arms control is disappearing before our eyes?